Judge Robinson: ANDA Defendant Enjoined from Launching Generic Drug Until Court’s Decision Issues

Posted byYoung Conaway StaffPosted inSue L. Robinson, Senior Judge

In OSI Pharmaceuticals, Inc. v. Mylan Pharmaceuticals, Inc., C.A. No. 09-185-SLR (D. Del. June 30, 2011), Judge Robinson recently issued an order enjoining an ANDA defendant “from launching its generic drug until the court’s decision issues” because the stipulated post-trial briefing schedule would exceed “what the court estimates to be the expiration of the 30-month stay invoked by operation of the filing of this lawsuit[.]” Id.


OSI Pharm., Inc. v. Mylan Pharm., Inc., C.A. No. 09-185-SLR (D. Del. June 30, 2011)

(function() { var scribd = document.createElement(“script”); scribd.type = “text/javascript”; scribd.async = true; scribd.src = “https://www.scribd.com/javascripts/embed_code/inject.js”; var s = document.getElementsByTagName(“script”)[0]; s.parentNode.insertBefore(scribd, s); })();